O60504 (VINEX_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 134.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Vinexin Alternative name(s): SH3-containing adapter molecule 1 Short name=SCAM-1 Sorbin and SH3 domain-containing protein 3 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 671 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Vinexin alpha isoform promotes up-regulation of actin stress fiber formation. Vinexin beta isoform plays a role in cell spreading and enhances the activation of JNK/SAPK in response to EGF stimulation by using its third SH3 domain. |
| Subunit structure | Interacts with DLG5 through its third SH3 domain By similarity. Interacts with vinculin by the first two SH3 domains and the proline rich region of vinculin. Binds to SOS (guanine nucleotide exchange factor of RAS and RAC), through its third SH3 domain. The formation of this complex is down-regulated by phosphorylation of SOS. Interacts with INPPL1/SHIP2, SAFB2, SOCS7 and SRCIN1. Interacts with FASLG. Interacts with MAPK1/ERK2 By similarity. Ref.6 Ref.7 Ref.8 Ref.9 Ref.12 Ref.14 |
| Subcellular location | Isoform Alpha: Cell junction By similarity. Cytoplasm › cytoskeleton By similarity. Note: Localized at cell-extracellular matrix junctions By similarity. Both isoforms were localized at focal adhesion and cell-cell adhesion sites. Isoform Beta: Cell junction By similarity. Nucleus. Cytoplasm › cytoskeleton By similarity. Note: Localized at cell-extracellular matrix junctions By similarity. Both isoforms were localized at focal adhesion and cell-cell adhesion sites, vinexin beta was also found in the nucleus. |
| Tissue specificity | Both isoforms are expressed in different tissues like heart, placenta, brain, skeletal muscle and pancreas. Isoform beta is especially found in liver. |
| Post-translational modification | Phosphorylated at Ser-530 by MAPK1/ERK2 during cell spreading By similarity. |
| Sequence similarities | Contains 3 SH3 domains. Contains 1 SoHo domain. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| SAFB2 | Q14151 | 3 | EBI-1222956,EBI-352869 | |
| Srcin1 | Q9QWI6-2 | 4 | EBI-1222956,EBI-775607 | From a different organism. |
| WASL | O00401 | 2 | EBI-1222956,EBI-957615 |
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform Alpha (identifier: O60504-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform Beta (identifier: O60504-2) The sequence of this isoform differs from the canonical sequence as follows: 1-342: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 671 | 671 | Vinexin | PRO_0000065830 | |||||||||||||||||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||||||||||||||||
| Domain | 115 – 187 | 73 | SoHo | ||||||||||||||||||||||||||||||||||||||||||||
| Domain | 380 – 439 | 60 | SH3 1 | ||||||||||||||||||||||||||||||||||||||||||||
| Domain | 454 – 515 | 62 | SH3 2 | ||||||||||||||||||||||||||||||||||||||||||||
| Domain | 612 – 671 | 60 | SH3 3 | ||||||||||||||||||||||||||||||||||||||||||||
| Region | 380 – 515 | 136 | Binds to vinculin | ||||||||||||||||||||||||||||||||||||||||||||
| Region | 612 – 671 | 60 | Binds to SOS | ||||||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 348 | 1 | Phosphoserine Ref.15 Ref.17 | ||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 395 | 1 | Phosphoserine Ref.17 | ||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 530 | 1 | Phosphoserine; by MAPK1 Ref.11 Ref.13 Ref.16 Ref.17 | ||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 544 | 1 | Phosphoserine Ref.18 | ||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 545 | 1 | Phosphoserine Ref.17 Ref.18 | ||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 551 | 1 | Phosphoserine Ref.13 Ref.17 | ||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 563 | 1 | Phosphoserine Ref.13 Ref.16 Ref.17 Ref.18 | ||||||||||||||||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 1 – 342 | 342 | Missing in isoform Beta. | VSP_004489 | |||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 255 | 1 | P → L. Corresponds to variant rs3758036 [ dbSNP | Ensembl ]. | VAR_057019 | |||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 556 | 1 | I → T. Ref.1 Ref.2 Ref.3 Ref.5 Ref.13 Ref.15 Ref.16 Ref.17 Ref.18 Ref.20 Ref.21 Corresponds to variant rs2449331 [ dbSNP | Ensembl ]. | VAR_055019 | |||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 573 | 1 | T → A. Corresponds to variant rs1047030 [ dbSNP | Ensembl ]. | VAR_055020 | |||||||||||||||||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 649 | 1 | W → F: Loss of SOS-binding ability. | ||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 667 | 1 | Y → V: Loss of SOS-binding ability. | ||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 583 | 1 | L → F in AAD32304. Ref.1 | ||||||||||||||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 385 – 389 | 5 | |||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 395 – 398 | 4 | |||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 406 – 414 | 9 | |||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 417 – 422 | 6 | |||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 425 – 435 | 11 | |||||||||||||||||||||||||||||||||||||||||||||
| Helix | 453 – 455 | 3 | |||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 456 – 461 | 6 | |||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 469 – 472 | 4 | |||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 480 – 485 | 6 | |||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 489 – 495 | 7 | |||||||||||||||||||||||||||||||||||||||||||||
| Turn | 497 – 499 | 3 | |||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 502 – 506 | 5 | |||||||||||||||||||||||||||||||||||||||||||||
| Helix | 507 – 509 | 3 | |||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 510 – 514 | 5 | |||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 615 – 621 | 7 | |||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 637 – 644 | 8 | |||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 646 – 648 | 3 | |||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 650 – 657 | 8 | |||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 660 – 663 | 4 | |||||||||||||||||||||||||||||||||||||||||||||
| Turn | 665 – 667 | 3 | |||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 668 – 670 | 3 | |||||||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Vinexin: a novel vinculin-binding protein with multiple SH3 domains enhances actin cytoskeletal organization." Kioka N., Sakata S., Kawauchi T., Amachi T., Akiyama S.K., Okazaki K., Yaen C., Yamada K.M., Aota S. J. Cell Biol. 144:59-69(1999) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM BETA), ALTERNATIVE SPLICING, MUTAGENESIS, VARIANT THR-556. Tissue: Placenta. |
| [2] | Her J.-H., Gorman D., Miyajima A., Bolen J.B. Submitted (DEC-1997) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM ALPHA), VARIANT THR-556. |
| [3] | "DNA sequence and analysis of human chromosome 8." Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S., Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A., Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., Allen N.R., Anderson S., Asakawa T. Lander E.S.Nature 439:331-335(2006) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], VARIANT THR-556. |
| [4] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS ALPHA AND BETA), VARIANT THR-556. Tissue: PNS and Uterus. |
| [6] | "Vinexin forms a signaling complex with Sos and modulates epidermal growth factor-induced c-Jun N-terminal kinase/stress-activated protein kinase activities." Akamatsu M., Aota S., Suwa A., Ueda K., Amachi T., Yamada K.M., Akiyama S.K., Kioka N. J. Biol. Chem. 274:35933-35937(1999) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH SOS. |
| [7] | "SAFB2, a new scaffold attachment factor homolog and estrogen receptor corepressor." Townson S.M., Dobrzycka K.M., Lee A.V., Air M., Deng W., Kang K., Jiang S., Kioka N., Michaelis K., Oesterreich S. J. Biol. Chem. 278:20059-20068(2003) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH SAFB2. |
| [8] | "The suppressor of cytokine signaling (SOCS)-7 interacts with the actin cytoskeleton through vinexin." Martens N., Wery M., Wang P., Braet F., Gertler A., Hooghe R., Vandenhaute J., Hooghe-Peters E.L. Exp. Cell Res. 298:239-248(2004) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH SOCS7. |
| [9] | "SHIP2 interaction with the cytoskeletal protein Vinexin." Paternotte N., Zhang J., Vandenbroere I., Backers K., Blero D., Kioka N., Vanderwinden J.-M., Pirson I., Erneux C. FEBS J. 272:6052-6066(2005) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH INPPL1. |
| [10] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Cervix carcinoma. |
| [11] | "A probability-based approach for high-throughput protein phosphorylation analysis and site localization." Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P. Nat. Biotechnol. 24:1285-1292(2006) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-530, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [12] | "Characterization of a multidomain adaptor protein, p140Cap, as part of a pre-synaptic complex." Ito H., Atsuzawa K., Sudo K., Di Stefano P., Iwamoto I., Morishita R., Takei S., Semba R., Defilippi P., Asano T., Usuda N., Nagata K. J. Neurochem. 107:61-72(2008) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH SRCIN1. |
| [13] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-530; SER-551 AND SER-563, VARIANT [LARGE SCALE ANALYSIS] THR-556, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [14] | "Identification of SH3 domain interaction partners of human FasL (CD178) by phage display screening." Voss M., Lettau M., Janssen O. BMC Immunol. 10:53-53(2009) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH FASLG. |
| [15] | "Large-scale proteomics analysis of the human kinome." Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G., Mann M., Daub H. Mol. Cell. Proteomics 8:1751-1764(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-348, VARIANT [LARGE SCALE ANALYSIS] THR-556, MASS SPECTROMETRY. |
| [16] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-530 AND SER-563, VARIANT [LARGE SCALE ANALYSIS] THR-556, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [17] | "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis." Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-348; SER-395; SER-530; SER-545; SER-551 AND SER-563, VARIANT [LARGE SCALE ANALYSIS] THR-556, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [18] | "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation." Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B. Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-544; SER-545 AND SER-563, VARIANT [LARGE SCALE ANALYSIS] THR-556, MASS SPECTROMETRY. |
| [19] | "Solution structure of SH3 domains of human vinexin." RIKEN structural genomics initiative (RSGI) Submitted (OCT-2006) to the PDB data bank Cited for: STRUCTURE BY NMR OF 383-437 AND 615-671. |
| [20] | "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis." Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III J. Proteome Res. 7:1346-1351(2008) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT [LARGE SCALE ANALYSIS] THR-556, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [21] | "Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle." Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M. Mol. Cell 31:438-448(2008) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT [LARGE SCALE ANALYSIS] THR-556, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | AF064807 mRNA. Translation: AAD32304.1. AF037261 mRNA. Translation: AAC09244.1. AC037459 Genomic DNA. No translation available. CH471080 Genomic DNA. Translation: EAW63675.1. BC067260 mRNA. Translation: AAH67260.2. BC091514 mRNA. Translation: AAH91514.1. BC010146 mRNA. Translation: AAH10146.1. | ||||||||||||||||||||||||||||||
| IPI | IPI00419847. IPI00939882. | ||||||||||||||||||||||||||||||
| RefSeq | NP_001018003.1. NM_001018003.2. NP_005766.3. NM_005775.4. | ||||||||||||||||||||||||||||||
| UniGene | Hs.528572. | ||||||||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||||||||||||||
| ProteinModelPortal | O60504. | ||||||||||||||||||||||||||||||
| SMR | O60504. Positions 354-525, 615-671. | ||||||||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||||||||
| IntAct | O60504. 18 interactions. | ||||||||||||||||||||||||||||||
| MINT | MINT-262486. | ||||||||||||||||||||||||||||||
| STRING | 9606.ENSP00000240123. | ||||||||||||||||||||||||||||||
PTM databases | |||||||||||||||||||||||||||||||
| PhosphoSite | O60504. | ||||||||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||||||||
| PaxDb | O60504. | ||||||||||||||||||||||||||||||
| PRIDE | O60504. | ||||||||||||||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||||||||
| Ensembl | ENST00000240123; ENSP00000240123; ENSG00000120896. ENST00000428103; ENSP00000408476; ENSG00000120896. | ||||||||||||||||||||||||||||||
| GeneID | 10174. | ||||||||||||||||||||||||||||||
| KEGG | hsa:10174. | ||||||||||||||||||||||||||||||
| UCSC | uc003xbv.3. human. uc003xbw.4. human. | ||||||||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||||||||
| CTD | 10174. | ||||||||||||||||||||||||||||||
| GeneCards | GC08P022409. | ||||||||||||||||||||||||||||||
| H-InvDB | HIX0201306. | ||||||||||||||||||||||||||||||
| HGNC | HGNC:30907. SORBS3. | ||||||||||||||||||||||||||||||
| HPA | HPA015849. | ||||||||||||||||||||||||||||||
| MIM | 610795. gene. | ||||||||||||||||||||||||||||||
| neXtProt | NX_O60504. | ||||||||||||||||||||||||||||||
| PharmGKB | PA128394570. | ||||||||||||||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||||||||
| eggNOG | NOG256936. | ||||||||||||||||||||||||||||||
| HOGENOM | HOG000294090. | ||||||||||||||||||||||||||||||
| HOVERGEN | HBG054842. | ||||||||||||||||||||||||||||||
| InParanoid | O60504. | ||||||||||||||||||||||||||||||
| OMA | TPYRAMY. | ||||||||||||||||||||||||||||||
| OrthoDB | EOG457563. | ||||||||||||||||||||||||||||||
| PhylomeDB | O60504. | ||||||||||||||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||||||||||||||
| Reactome | REACT_17044. Muscle contraction. | ||||||||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||||||||
| ArrayExpress | O60504. | ||||||||||||||||||||||||||||||
| Bgee | O60504. | ||||||||||||||||||||||||||||||
| CleanEx | HS_SORBS3. | ||||||||||||||||||||||||||||||
| Genevestigator | O60504. | ||||||||||||||||||||||||||||||
| GermOnline | ENSG00000120896. Homo sapiens. | ||||||||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||||||||
| InterPro | IPR000108. p67phox. IPR011511. SH3_2. IPR001452. SH3_domain. IPR003127. Sorb. [Graphical view] | ||||||||||||||||||||||||||||||
| Pfam | PF00018. SH3_1. 2 hits. PF07653. SH3_2. 1 hit. PF02208. Sorb. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||
| PRINTS | PR00499. P67PHOX. PR00452. SH3DOMAIN. | ||||||||||||||||||||||||||||||
| SMART | SM00326. SH3. 3 hits. SM00459. Sorb. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||
| SUPFAM | SSF50044. SH3. 3 hits. | ||||||||||||||||||||||||||||||
| PROSITE | PS50002. SH3. 3 hits. PS50831. SOHO. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||||||||
Other | |||||||||||||||||||||||||||||||
| ChiTaRS | SORBS3. human. | ||||||||||||||||||||||||||||||
| EvolutionaryTrace | O60504. | ||||||||||||||||||||||||||||||
| GenomeRNAi | 10174. | ||||||||||||||||||||||||||||||
| NextBio | 38520. | ||||||||||||||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||||||||||||||
Entry information
| Entry name | VINEX_HUMAN | ||||||||
| Accession | Primary (citable) accession number: O60504 Secondary accession number(s): Q5BJE4 Q9UQE4 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 8 Human chromosome 8: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
